TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
EMBC

Embecta Corp

Healthcare · Medical Instruments & Supplies

5.90$ +0.5% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns Embecta Corp (EMBC)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 96.7% of the shares are freely tradable; institutional investors hold 90.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 90.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 96.7%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 13.3%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 57Mio.

Largest Shareholders

Institutions

Institutions EMBC
Name Stake (%) Shares Change (%) Date
BlackRock Inc 16.18 9,167,212 +2.2 03/31/2026
Yacktman Asset Management Co 7.62 4,315,952 +17.5 06/30/2026
Vanguard Capital Management, LLC 4.53 2,563,951 +0.0 03/31/2026
State Street Corp 4.49 2,545,973 +7.9 03/31/2026
Deerfield Management Co 4.47 2,534,961 -7.9 03/31/2026
Jefferies Financial Group Inc 4.16 2,355,162 +0.0 03/31/2026
Vanguard Portfolio Management, LLC 2.71 1,537,957 +0.0 03/31/2026

Funds

Funds EMBC
Name Stake (%) Shares Change (%) Date
AMG Yacktman I 6.18 3,500,000 +16.7 06/30/2026
Vanguard MStar Total Stk Mkt Idx Invest 3.23 1,831,834 +0.0 08/31/2026
iShares Russell 2000 ETF 2.84 1,608,969 -0.6 08/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings EMBC
Person Role Shares Value As of Type
Kurdikar Devdatt President and CEO 804,919 4,749,020 $ Aug 12, 2026 direct
Elguicze Jacob SVP and CFO 309,139 1,823,918 $ Aug 12, 2026 direct
Mann Jeffrey Z Pres, Pharm Svc&Prod Mgmt, CLO 262,915 1,551,199 $ Aug 12, 2026 direct
Hombach Robert J. Director 109,587 646,565 $ Aug 12, 2026 direct
Morris Milton Mayo Director 53,828 317,587 $ Sep 4, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 4, 2026 Morris Milton Mayo Director Sell 6,293 5.88 36,971
Aug 12, 2026 Kurdikar Devdatt President and CEO Buy 30,000 4.70 140,937
Aug 12, 2026 Elguicze Jacob SVP and CFO Buy 20,000 4.67 93,360
Aug 12, 2026 Mann Jeffrey Z Pres, Pharm Svc&Prod Mgmt, CLO Buy 20,000 4.99 99,800
Aug 12, 2026 Hombach Robert J. Director Buy 45,000 4.97 223,848

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?